Reuters logo
BRIEF-Medicenna reports Q2 loss per share C$0.07
November 13, 2017 / 12:19 PM / a month ago

BRIEF-Medicenna reports Q2 loss per share C$0.07

Nov 13 (Reuters) - Medicenna Therapeutics Corp

* Medicenna reports second quarter fiscal 2018 financial results

* Q2 loss per share C$0.07

* Medicenna Therapeutics Corp - ‍Medicenna ended quarter with a cash balance of $9.5 million​

* Medicenna Therapeutics Corp - ‍company has sufficient resources to fund research and development and operations into Q1 of calendar 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below